72 Investment Holdings, LLC
In its 13F for Q2 2025 (holdings as of June 30, 2025, filed August 14, 2025), 72 Investment Holdings, LLC reported 6 stock positions worth $38.3 million. Its top holding was Lenz Therapeutics (LENZ) at 77.8% of the portfolio, followed by Korro Bio (KRRO, 9.0%) and Praxis Precision Medicines I (PRAX, 7.2%). Its holdings were unchanged from Q1 2025.
- Most Recent 13F
- Q2 2026
- Location
- STAMFORD, CT
- CIK
- 0001832749
- Portfolio Value
- $38.3M (Q2 2025)
- SEC Filing
- 0000902664-25-003658 ↗ filed Aug 14, 2025
Holdings Value
Holdings 6 stocks · $38.3M
| LENZ Lenz Therapeutics Inc. | 77.84% | 1,017,751 | $29.8M | No change |
| KRRO Korro Bio Inc. | 9.02% | 276,831 | $3.5M | No change |
| PRAX Praxis Precision Medicines I | 7.23% | 65,933 | $2.8M | No change |
| ANRO Alto Neuroscience Inc. | 3.83% | 667,778 | $1.5M | No change |
| CRBU Caribou Biosciences Inc. | 1.56% | 474,067 | $597K | No change |
| TSBX Turnstone Biologics Corp. | 0.52% | 549,980 | $197K | No change |
Portfolio Sells Q1 2025 → Q2 2025
| None this quarter. | |||
Portfolio Buys Q1 2025 → Q2 2025
| None this quarter. | |||
All Filings
| Quarter | Positions | 13F Reported Value | Top Holdings |
|---|---|---|---|
| Q2 2026 | 5 | $50.0M | PRAX, ANRO, LENZ, KRRO, CRBU |
| Q1 2026 | 5 | $49.6M | PRAX, ANRO, LENZ, KRRO, CRBU |
| Q4 2025 | 5 | $50.6M | PRAX, LENZ, ANRO, KRRO, CRBU |
| Q3 2025 | 5 | $67.9M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q2 2025 | 6 | $38.3M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q1 2025 | 6 | $35.6M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q4 2024 | 7 | $49.1M | LENZ, KRRO, PRAX, ANRO, CRBU |
| Q3 2024 | 7 | $46.5M | LENZ, KRRO, ANRO, PRAX, CRBU |
| Q2 2024 | 7 | $39.8M | LENZ, KRRO, ANRO, PRAX, TSBX |
| Q1 2024 | 7 | $67.1M | KRRO, LENZ, ANRO, PRAX, CRBU |